Breaking News

You are here » Indian-Commodity  :  Equity & Shares  :  Caplin Point gains on receiving USFDA approval for Ketorolac Tromethamine Injection

20-Sep2017

Caplin Point gains on receiving USFDA approval for Ketorolac Tromethamine Injection

Caplin Point Laboratories is currently trading at Rs. 732.60, up by 5.65 points or 0.78% from its previous closing of Rs. 726.95 on the BSE.

The scrip opened at Rs. 730.00 and has touched a high and low of Rs. 745.00 and Rs. 721.90 respectively. So far 17,104 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 783.90 on 07-Aug-2017 and a 52 week low of Rs. 240.00 on 29-Sep-2016.

Last one week high and low of the scrip stood at Rs. 745.00 and Rs. 685.55 respectively. The current market cap of the company is Rs. 5,536.00 crore.

The promoters holding in the company stood at 69.06%, while Institutions and Non-Institutions held 5.86% and 25.08% respectively.

Caplin Point Laboratories has received approval from the U.S. Food and Drug Administration (USFDA) of its Abbreviated New Drug Application (ANDA) for Ketorolac Tromethamine Injection 30mg/mL, a product developed for Cycle Pharmaceuticals. Ketorolac Tromethamine Injection is a nonsteroidal anti-inflammatory drug (NSAID) and is indicated for the short-term (up to 5 days in adults) management of moderately severe acute pain that requires analgesia at the opioid level.

Ketorolac Tromethamine Injection has been developed at Caplin Point and will be manufactured at Caplin's FDA approved site. Cycle has selected Virtus Pharmaceuticals, LLC (Virtus) as the importer and distributor of Ketorolac Tromethamine Injection in the U.S.

Caplin Point Laboratories is engaged mainly in manufacturing a wide range of Ointments, Creams and other External application preparations in addition to the regular segments of pharmaceutical formulations.



Related News

View all news

United Bank of India shines on getting nod to raise Rs 1,500 crore by various means

United Bank of India is currently trading at Rs. 11.05, up by 0.50 points or 4.74% from its previous closing of Rs. 10.55 on the BSE.The scrip opened at Rs. 10.85 and has touched a high and low of Rs.......

Pondy Oxides & Chemicals gains on planning to merge Meloy Metals with itself

Pondy Oxides & Chemicals is currently trading at Rs. 319.80, up by 1.85 points or 0.58% from its previous closing of Rs. 317.95 on the BSE.The scrip opened at Rs. 317.80 and has touched a high......

Venky's slips on reporting 41.52% fall in Q4 net profit

Venky's  (India) is currently trading at Rs. 1766.00, down by 56.15 points or 3.08% from its previous closing of Rs. 1822.15 on the BSE.The scrip opened at Rs. 1817.00 and has touched a high and......

Top News

View all news

SRF, NIIT Technologies and United Bank of India to see some action today

SRF has entered into a definitive agreement to sell its Engineering Plastics Business to DSM, the Life Sciences and Materials Sciences Company in an all-cash transaction, amounting to Rs 320 crore. The......

NIIT Technologies concludes sale of 88.99% stake in ESRI India Technologies

NIIT Technologies has concluded the sale of 88.99% equity shares in ESRI India Technologies, India to Environment Systems Research Institute Inc., USA. Consequent to above sale, ESRI India Technologies,......

United Bank of India to raise Rs 1,500 crore by various means

United Bank of India has received approval to raise equity capital not exceeding Rs 1,500 crore in one or more tranches during the financial year by way of Qualified Institutions Placement, Public Issue,......